Navigation Links
Founder of Curidium Launches Elixior, an Advisory Company Focused on the Development and Growth of Innovative Personalized Medicine Businesses
Date:9/6/2009

LONDON, September 7 /PRNewswire/ -- Elixior Limited, the advisory company focused on the development and growth of innovative personalized medicine businesses, announced today its launch by the founder and former CEO of Curidium, Dr Anne Bruinvels.

    Elixior's business activities are aimed at:

    - Supporting the development and growth of personalized medicine
      businesses through the creation of partnerships and / or the sourcing
      of investments

    - Helping personalized medicine companies with the structuring of their
      corporate and commercial strategies

    - Conducting due diligence on personalized medicine ventures

    - Building a world-wide, personalized medicine knowledge-base to support
    cooperation between personalized medicine businesses and the growth of
    the sector.

Dr Anne Bruinvels, founder and CEO of Elixior, commented: "The field of personalized medicine is moving forward rapidly and it is Elixior's aim to help the development and commercialization of new innovations in this exciting area. Personalized medicine has the potential to treat patients more effectively and to make healthcare much more cost-effective over time. I look forward to working with small and big companies alike planning to move into or expand in this field."

Previously, Dr Anne Bruinvels founded Curidium, a personalized medicine company focused on improving the diagnosis and treatment of central nervous system disorders. She was Curidium's CEO for more than six years, during which she took the company public on the AIM of the London Stock Exchange.

About Personalized Medicine

The term personalized medicine means the use of molecular analysis methods to better manage a patient's disease or disease predisposition. These methods include testing for variations in genes, gene expression, proteins, and metabolites. Test results are correlated with clinical factors-such as drug response, disease state, and treatment prognosis-and help physicians individualize treatment for each patient.

Further information on Elixior can be found at the Company's website: http://www.elixior.com. or further information, please contact:

    Anne Bruinvels, CEO
    Phone: +44(0)77-67-807-865
    E-mail: anne.bruinvels@elixior.com



'/>"/>
SOURCE Elixior Limited
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Kenneth G. Langone, Home Depot Co-Founder, Chairman of the NYU Langone Medical Center, to Lead 65th Annual Columbus Day Parade as Grand Marshal
2. Laurence Barsh, DMD, Founder of Snoring Isn't Sexy, LLC Emphasizes Need to Evaluate and Treat Sleep Patients
3. AMERIGROUP Foundation Honors Warehouse of Hope Founder Craig Parson as a Healthy Hero
4. Laurence I. Barsh, DMD, Founder of Snoring Isn't Sexy, to speak at Somnomed's First Annual Symposium
5. Randall Terry, Founder, Operation Rescue: Abortion, Healthcare, and Social Upheaval: Pro-life Leaders to Discuss Backlash -- Including Potential of Unwanted Violence
6. Miles To End Malaria Program Gets an Extra Burst of Speed From American Le Mans Series Founder Don Panoz
7. Founders of Running Skirts Inc. Set to Launch New Maternity Line
8. Founder and CEO of HealthTech, Molly Coye, MD, Assumes Leadership of CalRHIO
9. Angelo Masciantonio, CEO and Co-Founder of HTH Worldwide Named Ernst & Young 2009 Entrepreneur Of The Year(R) in Greater Philadelphia
10. Chopra Center Co-Founder and Best-Selling Author David Simon, M.D., Will Lead Two Special Events in New York City This June
11. Medeguide Founder to Lead Online Healthcare Marketing Workshop at the Healthcare Travel Conference in Singapore
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... 26, 2017 , ... Amir Qureshi, MD is the first physician in Arkansas ... stimulation system. The Nuvectra™ Algovita SCS System has been FDA approved as a treatment ... in Arkansas to introduce the most powerful SCS system and the only stretchable lead ...
(Date:5/26/2017)... ... May 26, 2017 , ... On May 24, the ... narrowly passed the U.S. House on May 4, would result in 23 million Americans ... continued implementation of the 2010 Patient Protection and Affordable Care Act (ACA). , ...
(Date:5/26/2017)... ... May 26, 2017 , ... Dr. Alex Rabinovich, a ... announce a new, informational blog post on insurance options. If a Bay Area patient ... may help save time and money. Visiting an in-network provider for a second opinion ...
(Date:5/26/2017)... , ... May 26, 2017 , ... “Cactus Jack: Against ... on so many others. “Cactus Jack: Against All Odds” is the creation of ... Walter D. Hubbard is married to Jack Carlisle’s third child Jane. Walter. Walter ...
(Date:5/24/2017)... Hills, CA (PRWEB) , ... May 24, 2017 , ... ... announced today its participation in nVerge 2017 – a one-day technology conference in San ... Altec’s document management solution, which allows users to fully utilize and enhance their Sage ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... 10, 2017  The Corporate Whistleblower Center says, ... sleep therapy clinics to call us anytime at ... is involved in a substantial scheme to overbill ... from an employee of a medical equipment company ... to provide medical practice groups with extra generous incentives ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals ... ), a clinical-stage pharmaceutical company focused on the ... that the Canadian Intellectual Property Office has granted ... Oral Administration of Exenatide". The patent covers Oramed,s ... GLP-1 is an incretin hormone that ...
(Date:5/6/2017)... , May 5, 2017  May is Stroke ... one of the most important methods to prevent a ... the Centers for Disease Control and Prevention, undetected and ... 1 Omron, the global leader in personal heart ... the elimination of heart attack and stroke and is ...
Breaking Medicine Technology: